Search
for

    Sort by

    Research 781–810 of 1000+

    1. Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement Australasian Journal of Dermatology · 2025
    2. Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity Diseases · 2025
    3. Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy Preprints.org · 2025
    4. Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease Dermatopathology · 2025
    5. Assessment of Vascular Circulation in Alopecia Areata Using the FMSF Technique Journal of Clinical Medicine · 2025
    6. Comprehensive Review on Hair Loss and Restorative Techniques: Advances in Diagnostic, Artistry, and Surgical Innovation Cureus · 2025
    7. Recent Advances in Drug Development for Hair Loss International Journal of Molecular Sciences · 2025
    8. Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities Cureus · 2025
    9. Serum Vitamin D Level in Pediatric Alopecia Areata Indian Journal of Paediatric Dermatology · 2025
    10. Uncommon Presentation of Pityriasis Rubra Pilaris of the Scalp: Clinical, Trichoscopic, and Histopathologic Features and Review of the Literature Medicina · 2024
    11. TLR9 activation in large wound induces tissue repair and hair follicle regeneration via γδT cells Cell Death and Disease · 2024
    12. Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report Clinical Cosmetic and Investigational Dermatology · 2024
    13. Diphenylcyclopropenone in severe alopecia areata in children and adolescents: long-term follow-up and relapse rate Journal of the Egyptian Womenʼs Dermatologic Society · 2024
    14. Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences International journal of molecular sciences · 2024
    15. Wigs and Alopecia Areata: Psychosocial Impact and Economic Considerations Cosmetics · 2024
    16. Serum Zinc Concentration in Patients with Alopecia Areata Acta dermato-venereologica (Print) · 2023
    17. Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management Dermatology and Therapy · 2023
    18. An Updated in the Management of Alopecia Areata IntechOpen eBooks · 2023
    19. Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies Cancers · 2023
    20. Revolutionizing Radiotoxicity Management with Mesenchymal Stem Cells and Their Derivatives: A Focus on Radiation-Induced Cystitis International Journal of Molecular Sciences · 2023
    21. New Treatment Options for Alopecia Areata Hautnah · 2023
    22. Successful treatment of rare linear lichen planopilaris with Ixekizumab Journal of dermatological treatment · 2023
    23. Oral Combination Treatment of Gefitinib (IressaTM) and Sasam-Kyeongokgo: Synergistic Effects on the NCI-H520 Tumor Cell Line Applied sciences · 2023
    24. Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway Indian Dermatology Online Journal · 2023
    25. Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata Dermatology and therapy · 2022
    26. Alopecia Areata in Twins With Autoimmune Thyroiditis: Personal Observations Dermatology practical & conceptual · 2019
    27. Quoi de neuf en dermatologie pédiatrique ? Annales de dermatologie et de vénéréologie · 2017
    28. Keratin 15 Expression in Stratified Epithelia: Downregulation in Activated Keratinocytes Journal of Investigative Dermatology · 1999 · 198 citations
    29. Retinoids and Phototherapy for Psoriasis The Journal of Rheumatology Supplement · 2009 · 7 citations
    30. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment Gut · 2013 · 278 citations